The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Generation and functional characterization of MDSC-like cells
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Researchers release the brakes on the immune | EurekAlert!
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
Bjørn Heine Strand - NIPH
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
UKB NewsRoom | Annkristin Heine
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Immunotherapy as an advance in cancer medicine - Innovations Report
Volume 21, Issue 3, Pages (October 2017) - ppt download
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
